Project Details
| Short title | NSI-8226-201 |
|---|---|
| Acronym | ALAMERE |
| Status | Active |
| Effective start/end date | 22/11/24 → 12/09/29 |
CTU: A Phase 2, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study with an Open-Label Extension to Investigate the Efficacy and Safety of Solrikitug in Adults with Eosinophilic Esophagitis (ALAMERE)
- Shim, Lisa (Primary Chief Investigator)
- Martin, Lewis (Clinical Trial Unit Staff)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
Project: Research